This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Walter Pebley
Chief Science Officer at OFD Life Sciences
Speaker

Profile

Completing 44 years as primary research and scale-up Engineer for designing and commissioning internal proprietary and novel Lyophilization equipment for stabilizing materials to maximize efficacy, potency, solubility and bioavailability in a broad range of applications. Those applications cover Academic Institutions, Non-Profit Organizations, NIH, DARPA, BARDA, Fortune 500 Pharma and Biotech companies. Elected to Oregon State University Academy of Distinguished Engineers in 2019Patents:•1994 – Rapidly Disintegrating Tablet•2017 – Products and Devices for controlling and stopping Bleeding and Methods of Using •Patent Application – 2023 – Methods, Systems, and Materials for making unit dosage forms